Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria
Pages JM, Amaral L. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta 2009; 1794: 826-33.
Reversal of resistance in microorganisms by help of non-antibiotics
Kristiansen JE, Hendricks O, Delvin T et al. Reversal of resistance in microorganisms by help of non-antibiotics. J Antimicrob Chemother 2007; 59: 1271-9.
Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB
Amaral L, Martins A, Molnar J et al. Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB. In Vivo 2010; 24: 409-24.
The antibiotic effect of the anti-depressive drug femoxetine and its stereo-isomeric analogs on diarrhoea producing Enterobacteriaceae
Kristiansen JE, Mortensen I, Gaarslev K. The antibiotic effect of the anti-depressive drug femoxetine and its stereo-isomeric analogs on diarrhoea producing Enterobacteriaceae. Acta Pathol Microbiol Immunol Scand B 1986; 94: 103-6.
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates
Bohnert JA, Karamian B, Nikaido H. Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. Antimicrob Agents Chemother 2010; 54: 3770-5.
Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF)
Bohnert JA, Schuster S, Fähnrich E et al. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). J Antimicrob Chemother 2007; 59: 1216-22.
Medium plays a role in determining expression of acrB, marA, and soxS in Escherichia coli
Bailey AM, Webber MA, Piddock LJ. Medium plays a role in determining expression of acrB, marA, and soxS in Escherichia coli. Antimicrob Agents Chemother 2006; 50: 1071-4.
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy
Lomovskaya O, Warren MS, Lee A et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-16.
Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli
Kern WV, Oethinger M, Jellen-Ritter AS et al. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 2000; 44: 814-20.
Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone
Jellen-Ritter AS, Kern WV. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob Agents Chemother 2001; 45: 1467-72.
Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria
Tikhonova EB, Wang Q, Zgurskaya HI. Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria. J Bacteriol 2002; 184: 6499-507.